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Abstract 
During the acute phase of infection, T. cruzi replicates extensively and releases immuno-
modulatory molecules that delay parasite-specific responses mediated by effector T cells. This 
mechanism of evasion allows the parasite to spread in the host. Parasite molecules that 
regulate the host immune response during Chagas’disease have not been fully identified. 
GPI-anchored mucins, glycoinositolphospholipids, and glycoproteins comprise some of the 
most abundant T. cruzi surface molecules. IL-10 IFN-γ-secreting CD4+ T cells are activated 
during chronic infections and are responsible for prolonged persistence of parasite and for 
host protection against severe inflammatory responses. In this work we evaluated the role of 
rMBP::SSP4 protein of T. cruzi, a recombinant protein derived from a GPI anchored antigen, 
SSP4, as an immunomodulator molecule, finding that it was able to induce high concentrations 
of IL-10 and IFN-γ both in vivo and in vitro; during this last condition, both cytokines were 
produced by IL-10-IFN-γ-secreting CD4+ T cells. 
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Introduction 
Chagas’ disease is caused by the protozoan par-
asite Trypanosoma cruzi (1). It is estimated that 14-16 
million people in Latin America and 1 million in the 
US are infected with this parasite (2). The metacyclic 
trypomastigote  infects  host  cells  and  inside  them, 
differentiate  into  the  amastigote  forms  that  are  re-
sponsible for parasite replication. (3). During infection 
with T. cruzi, the activation of the immune system is 
likely to be involved in at least two aspects of Chagas’ 
disease  pathophysiology,  which  are,  the  control  of 
parasite replication and spread in the host tissues, and 
the inflammatory reaction in infected host tissues. At 
the  onset  of  infection,  T.  cruzi  activates  cells  from 
macrophage lineage to produce high levels of chem-
okines and proinflammatory cytokines. Most notably, 
cells  exposed  to  protozoan  products  will  produce 
IL-12 which is responsible for initiation of IFN-γ syn-
thesis (4, 5). On the other hand, IL-10 has also been 
associated  with  susceptibility  to  T.  cruzi  infection. 
IL-10  inhibits  macrophages  functions  including  the 
activation by IFN-γ to kill intracellular T. cruzi. Thus it 
seems that these two cytokines, IL-10 and IFN-γ are 
opposed in critical aspects of immunity in response to 
T. cruzi infection (6-8). 
Little  is  known  about  parasites  molecules  that 
trigger the innate immune system during early stages 
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of  protozoan  infections.  In  the  last  few  years,  the 
identification and structural characterization of para-
site molecules that initiates the synthesis of different 
cytokines and other molecules by immune cells has 
been  the  focus  of  many  studies.  Experimental  evi-
dence  strongly  suggests  that  GPI  anchors  derived 
from Plasmodium falciparum, Trypanosoma brucei and T. 
cruzi play an important role on the activation of the 
innate  immune  system  during  protozoan  infection 
(9-12).  
There are several reports describing CD4+ T cell 
clones  producing  IFN-γ  and  IL-10;  these  were  first 
obtained in 1999 from bronchoalveolar lavage fluid in 
acute  tuberculosis  patients  (13).  IL-10  and 
IFN-γ-secreting CD4+ T cells have been found during 
chronic infections, such as TB, Leishmania, Lyme dis-
ease, a T. gondii mouse model, and L. major. These cells 
are now considered able to prevent collateral immune 
damage, as well as being used by pathogens to pre-
vent their elimination (14). Under normal conditions 
there  is  no  substantial  co-expression  of  IL-10  and 
IFN-γ cells in IL-10 reporter mice, even in the intes-
tine, where most IL-10-secreting CD4+ cells reside. It 
is also known that a threshold of activation and re-
peated stimulation of the immune system are required 
for  the  generation  of  these  cells.  Parasite  molecules 
that may regulate host responses have not been fully 
explored (15). In the present work,  we investigated 
the role of rMBP::SSP4, a recombinant protein derived 
from Trypanosoma cruzi (a major surface glycoprotein 
(SSP4) that is bound to the plasma membrane by a 
GPI  anchor)  on  the  immune  system  as  a  result  of 
immunization. Results showed that this antigen was 
able to induce a broad range of cytokines such as IL-4, 
IL-10, IL-12, and TNF-α, and IFN-γ both in vivo and in 
vitro,  and  that  the  two  major  cytokines  produced, 
IL-10 and IFN-γ, were produced by CD4+ T cells, a 
regulatory  population  previously  described  and 
named IL-10-IFN-γ-secreting CD4+ T cells.  
Materials and Methods 
Mice 
C57BL/129  mice  were  housed  in  a  controlled 
microenvironment at the animal facility at Ohio State 
University  and  managed  according  to  institutional 
animal care guidelines. 
Mice Immunization 
Female C57BL/129 mice, aged 10-12 weeks were 
immunized  by  intraperitoneal  injection  with 
rMBP::SSP4 protein emulsified in complete Freund’s 
adjuvant  (CFA)  at  the  first  time  and  incomplete 
Freund’s adjuvant (IFA) the following times (Sigma). 
Each mouse was injected with 10 µg of rMBP::SSP4 in 
100 µL of PBS mixed with 100 µL of CFA or IFA, on 
days 1, 7, and 14. Control mice were injected with 100 
µL of PBS plus CFA/IFA following the same proce-
dure.  
Antibody Isotyping by ELISA 
Fourteen days after the last immunization mice 
were sacrificed and bleed and sera was used to de-
termine  the  isotype  of  produced  antibodies.  Immu-
noglobulin  (Ig)  G1  and  IgG2a  were  evaluated  by 
ELISA. Plates were coated with 5 µg of rMBP::SSP4 in 
carbonate buffer, pH 9.0 and incubated at 4 ºC over-
night. Plates were washed and blocked with 200 µL 
per well of 5 % non-fat milk in PBS for 1 h at 37 ºC. 
Plates were washed and incubated with immune se-
rum (anti-rMBP::SSP4) for 2 h at 37 ºC. After washing, 
100  µL  per  well  peroxidase-labelled  rat  anti-mouse 
IgG subclass antibodies (1:5000 dilution) were added 
(Pharmingen), diluted in PBS-25% FBS and incubated 
for  2  h  at  37  ºC.  After  incubation,  N.N.-Dimethyl-
formamide  plus  ABTS  (2,2’-azino-di-(3- 
ethylbenzthiazoline-6-sulfonate) were added as sub-
strate, 10 min later, the reaction was stopped with 50 
µL of 5% phosphoric acid and plates were read im-
mediately at 450 nm.  
In vitro splenocytes culture. 
Spleen  cells  from  immunized  or  control 
C57BL/129  mice,  were  incubated  with  DMEM  con-
taining 10% FCS at 37 ºC in 5% CO2 in 24-well plates 
(2 x106 cells/well). Spleen cells were cultured sepa-
rately in the presence of 10 µg/mL rMBP::SSP4 pro-
tein,  4  µg/mL  Concanavalin  A  (ConA)  or  medium 
alone in 24-well plates (Costar). Culture supernatants 
were collected after 72 h and cytokine concentrations 
were determined. All experiments were controlled for 
stimulation with MBP alone (data not shown). 
Determination of Cytokine pattern by ELISA 
Interleukin  4  (IL-4),  IL-6,  IL-10,  IL-12,  TNF-α, 
and IFN-γ were quantified by ELISA in culture su-
pernatants of spleen cells under different conditions 
of re-stimulation, and in sera, according to the manu-
facturer’s protocol. Briefly, 96 well flat bottom plates 
were  coated  over  night  with  capture  antibody  at  a 
final  antibody  concentration  of  2  μg/mL,  and  then 
plates were blocked with 10% PBS-FCS, washed three 
times and incubated with the antigen overnight at 4 
ºC. After washing, plates were incubated with bioti-
nylated anti-cytokine Ab at 1 μg/mL for 1 h in the 
dark. Plates were washed and streptavidin-Alkaline 
Phosphatase at 1:2000 was added for 30 min in the 




Phenyl  Phosphate  (pNPP)  substrate  were  added  to 
each well and incubated until the color changed (ap-
proximately 1 h). Plates were read at 405 nm. 
Flow Cytometry Analysis and Intracellular 
Staining 
Spleen cells from immunized and non immun-
ized  mice,  cultured  for  72  h,  were  stained  with  PE 
anti-mouse-CD4  or  APC  anti-mouse-CD8  according 
to  the  manufacture’s  protocol.  Briefly,  nonspecific 
staining was blocked with anti-CD16/CD32 mAb (Fc 
block).  Cells  were  incubated  with  appropriate  anti-
bodies for 30 min on ice, and washed twice with PBS 
containing  2%  FCS.  Working  solutions  of  (1X) 
Fix/Perm buffer and Perm buffer were prepared prior 
to intracellular staining. Once prepared, 1 mL of 1X 
Fix/Perm solution was added to each tube, vortexed 
and incubated at room temperature in the dark for 20 
min, then cells were spin down and the supernatant 
was removed. Cells were washed and re-suspended 
in 1 mL 1X Perm buffer, incubated at room tempera-
ture in the dark for 15 min, spin down and the su-
pernatant  was  discarded.  Then,  the  respective  anti-
bodies were added: APC anti-mouse-IL-10 antibody 
or PE-anti-mouse IFN-γ antibody to the appropriate 
tubes, and incubated at room temperature in the dark 
for 30 min. Finally, samples were washed twice with 
cell staining buffer and re-suspended in 0.5 mL cell 
staining buffer. Samples were read in a FACS Calibur. 
Statistical analysis 
Analyses  were  performed  using  GraphPad 
Prism version 5.0 software. Differences were consid-
ered significant when a p value of less than 0.05 was 
obtained. 
Results and Discussion 
Parasite persistence depends on a combination 
of factors, including release of molecules that interfere 
with the immune response. Early work demonstrated 
that  T.  cruzi  suppresses  lymphocyte  activation,  an 
effect that depends on the density of parasites (16). 
Therefore, suppression induced by parasite molecules 
is more relevant at the acute phase, when the concen-
tration of such molecules can be fairly high. The best 
characterized  parasite  molecules  are  surface  glyco-
sylphosphatidylinositol (GPI)-anchors, to which both 
pro- and anti-inflammatory effects have been ascribed 
(17).  TcSSP4,  the  gene  that  codifies  for  a  T.  cruzi 
amastigote-specific  surface  GPI  anchored  antigen 
which is released to the culture medium by phospho-
lipase C activity, was cloned in the EcoR1 site of the 
expression vector pMAL-C2, resulting in the plasmid 
pMAL-TcSSP4. This plasmid was used to transform E. 
coli  DH5-α,  to  obtain  the  recombinant  protein 
MBP::SSP4 (rMBP::SSP4). 
Ramos-Ligonio et al., (2004) demonstrated that 
rMBP::SSP4 is a modulator of humoral and cellular 
immune responses, inducing low levels of IgA, IgM 
and IgG3, but high levels of IgG1, IgG2a and IgG2b 
isotypes; moreover, rMBP::SSP4 induced the expres-
sion of iNOS and the production of NO by  macro-
phages.  rMBP::SSP4  was  also  able  to  induce  the 
mRNA for IL-1α, IL-6, IL-12, IFN-γ and TNF-α cyto-
kines in control mice and IL-10 in immunized mice, 
suggesting that TcSSP4 might exert a regulatory in-
fluence on macrophages during the immune response 
against T. cruzi. 
Based on this knowledge, we assessed the anti-
gen-specific humoral and cellular immune responses 
induced  by  rMBP::SSP4  in  C57BL/129  mice,  a  re-
sistant  strain  model  of  T.  cruzi  infection.  Results 
showed that the isotype pattern was maintained after 
immunization with rMBP::SSP4, showing high levels 
of IgG1 and IgG2a, confirming the immunogenicity of 
SSP4 (Table 1). We then examined the serum cytokine 
profile from immunized and non-immunized mice in 
response to antigen stimulation. Results showed that 
this antigen induces the secretion of several cytokines 
such as IL-4, IL-10, IFN-γ, and TNF-α in considerable 
amounts, whereas IL-12 was produced at a very low 
level, suggesting that SSP4 is an immunomodulator 
molecule of T. cruzi (Fig. 1A). To assess whether local 
cytokine  profile  in  the  spleens  of  immunized  and 
non-immunized  mice  was  consistent  with  systemic 
cytokine levels in vivo, we determined the profile of 
cytokines in the supernatants of spleen cells of both 
groups under re-stimulation conditions (Fig. 1B). Re-
sults confirmed that the same cytokine profile is pre-
sent  in vitro;  IL-4,  IL-10,  IL-12, and  IFN-γ  were  de-
tected in the supernatants of immunized mice. How-
ever, IL-12 production by cells from immunized mice 
was  lower  than  that  produced  by  non-immunized 
cells  when  they  were  re-stimulated  in  vitro  with 
rMBP::SSP4.  These  results  clearly  showed  that  the 
immune  response  induced  in  vivo  is  maintained  in 
vitro.  However,  higher  concentrations  of  cytokines 
were found in the serum in comparison with those 
present in the supernatants from spleen cells (Fig. 1); 
either IL-5 nor IL-6 were detected in serum or culture 
supernatants  even  under  re-stimulation  (data  not 
shown). Supernatants of inguinal lymph nodes were 
also analyzed finding only IL-10 (data not shown). It 
is important to mention that the two major cytokines 
found were IL-10 and IFN-γ, which have been broadly 
studied during T. cruzi infection and have been shown 






Fig. 1. Cytokines profiles induced in vivo (A) and in vitro (B) after rMBP::SSP4 immunization. Mice were bleed two weeks after 
the third immunization and cytokines were measured in sera and culture supernatants from spleen cells by ELISA. Spleen 
cells were harvested after 72 h. A) IL-4, IL-10, IL-12, IFN-γ and TNF-α in serum from both groups of mice, immunized (full 
bars) and non-immunized (open bars). B) IL-4, IL-10, IL-12 and IFN-γ production by spleen cells under different conditions 
of re-stimulation: NS, (non-stimulated), ConA and rMBP::SSP4 for immunized (full bars) and non immunized mice (open 
bars). Histograms show values in ng/mL (mean±SD) of three experiments run in duplicate. 









We then proceeded to define the T cell subpop-
ulation(s) responsible of IL-10 and IFN-γ production. 
Spleen cells from C57BL/129 mice were stained for 
CD4 surface marker and then for intracellular IL-10. 
Results showed that IL-10 was indeed produced by 
CD4+ T cells after immunization and re-stimulation 
conditions,  finding  a  clear  difference  between  im-
munized  and  non-immunized  mice  (20.84%  versus 
10.36%) (Fig. 2A). T cells, both CD4+ and CD8+, and 
NK  cells  are  among  the  major  producers  of  IFN-γ. 
Because  high  levels  of  this  cytokine  were  also  pro-
duced  after  rMBP::SSP4  immunization,  we  also 
looked for its cell source. The presence of IFN-γ was 
analyzed in spleen cells after re-stimulation in CD4 
and  CD8  T  cells.  In  immunized  mice,  this  cytokine 
was produced by CD4+ T cells, similar to the produc-
tion of IL-10, finding that 23.15% of CD4 T cells were 
IFN-γ producers in comparison with only 10.77% of 
CD4+  T  cells  from  non-immunized  mice  under 
rMBP::SSP4 stimulation (Fig. 2B). CD8+ T cells didn’t 
produce IFN-γ in considerable amounts, neither from 
immunized  or  non-immunized  mice,  even  under 
re-stimulation conditions.  
After  finding  that  IL-10  and  IFN-γ  were  pro-
duced by CD4+ T cells, and having knowledge that 
after  repeated  stimulation  with  some  antigens, 
IL-10-IFN-γ-secreting T cells can be induced, we were 
interested in looking for double producer cells in this 
model.  Results  showed  that  IL-10  and  IFN-γ  were 
simultaneously  produced  by  CD4+  T  cells;  a  clear 
difference  was  observed  between  spleen  cells  from 
immunized mice (16.34%) and non-immunized mice 
(1.98%)  under  re-stimulation  condition  with 
rMBP::SSP4 (Fig. 2C). No differences between groups 
were  observed  in  the  condition  where  cells  didn’t 
receive stimulus or were stimulated with ConA. 
 
 






Fig. 2. CD4+ T cells produce both IL-10 and IFN-γ as a result of rMBP::SSP4 immunization and re-stimulation. Spleen cells 
from non-immunized (NIM) and immunized (IM) mice were cultured under different conditions of re-stimulation: NS, ConA 
and rMBP::SSP4 for 72 h. A) Dot blots graphs showing the production of intracellular IL-10 in gated CD4+ cells. B) Cells 
were stained for surface CD4 or CD8. Subsequently cells were stained for intracellular IFN-γ. Live cells were gated and 
CD4+ cells and CD8+ as well were selected. Density plots show the production of intracellular IFN-γ. The percentage of 
IFN-γ positive cells is indicated in each panel. C) Spleen cells suspensions were cultured under different conditions of 
re-stimulation as above, and CD4+ cells were selected and subsequently stained for intracellular IFN-γ and IL-10. Density 
plots show the production of both intracellular cytokines in CD4+ cells. The percentage of double cytokine positive cells is 





Therefore,  based  on  the  above  results,  we 
demonstrate that MBP::SSP4, a recombinant protein 
derived  of  T.  cruzi,  induces  IL-4,  IL-10,  IL-12,  and 
IFN-γ in vitro and IL-4, IL-10, IFN-γ and TNF-α in vivo 
as a result of immunization, and that the two major 
cytokines produced in vitro were IL-10 and IFN-γ both 
of  which  were  produced  by  IL-10-IFN-γ-secreting 
CD4+T  cells  (double  producers).  Studies  done  with 
other  T.  cruzi  derived  recombinant  protein 
(rMBP::TcHsP70 administered with or without adju-
vant) and in one case  with the same  immunization 
scheme, did not induce the same pattern of cytokines 
production  (unpublished  data).  Therefore,  we  can 
conclude that the immune response induced by SSP4 
is specific for this particular antigen. 
Regulatory  T  cells  are  groups  of  T  cells  that 
maintain  lymphocyte  homeostasis  and  immune  tol-
erance and down-regulate immune responses to pre-
vent excessive immune responses against pathogens 
(19).  Tregs  include  naturally  occurring  thy-
mus-derived Foxp3+ CD25+ T cells, induced Foxp3+ 
CD4+ T cells, and Foxp3+/- IL-10 secreting CD4+ T 
cells.  Although  IL-10-IFN-γ-secreting  CD4  T  cells 
have  been  recognized  for  many  years,  it  was  only 
discovered recently that the IL-10 IFN-γ-secreting T 
bet+ T cells in a T. gondii infection mouse model were 
required to prevent early mortality caused by exces-
sive inflammation (15). Similar results were obtained 
in  a  cutaneous  L. major infection  model  (20).  These 
cells  are  required  for  maintaining  a  chronic,  no  re-
solving infection status. There are evidences that these 
IL-10 IFN-γ-secreting CD4+ T cells are also suppres-
sive, data that can explain the low proliferation ob-
served  in  spleen  cells  proliferation  assays.  IL-10 
IFN-γ-secreting  CD4+  T  cells  are  antigen-induced; 
these double producers’ cells are usually generated in 
a strong immune-stimulating environment and they 
mediate the suppressive function through IL-10 with 
the help of IFN-γ (21). These cells are now considered 
able to prevent collateral immune damage, and also it 
has been described that these cells could be used by 
pathogens  to  prevent  their  elimination;  this  is  one 
more useful data to explain the long persistence of T. 
cruzi on its host. 
In conclusion, IL-10 IFN-γ-secreting CD4+ T cells 
are suppressive cells that play an important role in 
regulating  immune  responses.  Thus,  activation  of 
these cells may result in curable autoimmune diseas-
es. However, their modulation for infectious diseases 
treatment could be more complicated, as inhibition of 
these cells would also lead to over immune responses. 
Investigating how to balance IL-10 and IFN-γ secre-
tion by these cells, might provide better management 
for  those  infectious  diseases,  where 
IL-10-IFN-γ-secreting  cells  play  a  role  in  infection 
control. 
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